Search

Background: The incidence of recurrent nasopharyngeal carcinoma (NPC) after primary radiotherapy is considerable. The result of re-irradiation to the recurrent tumor is not satisfactory., Methods: Thirty-one patients who received nasopharyngectomy for treatment of their recurrent nasopharyngeal carcinoma (NPC) (rT1 to rT3) at the Prince of Wales Hospital during the period 1986 to 1997 were reviewed retrospectively. Eleven patients had nasopharyngectomy performed by the transoropalatal approach, 9 patients by the maxillary swing approach, and 11 patients by the mandibular approach., Results: Most recurrences (29 of 31) were rT1 and rT2 tumors. No hospital mortality occurred. The common complications of nasopharyngectomy were palatal defect (17 of 31), trismus (15 of 31), otitis media with effusion (20 of 31), dysphagia (12 of 31), and nasal regurgitation (8 of 31). Nine surgical specimens had microscopic invasion of the resection margins. The 5-year actuarial overall survival, actuarial disease-free survival, and tumor control were 47%, 42%, and 43%, respectively. The administration of postoperative radiotherapy significantly enhanced survival and tumor control after nasopharyngectomy., Conclusions: Nasopharyngectomy supplemented by postoperative radiotherapy achieved significant survival and tumor control with acceptable complications in selected recurrent NPC. It appears to be a better salvage treatment than re-irradiation alone for selected recurrent NPC.

The aim of this study was to define the risk of tongue and other aerodigestive tract cancers developing after primary radiation therapy for nasopharyngeal carcinoma (NPC). A cohort of 903 patients with non-disseminated NPC given radical radiotherapy between 1984 and 1989 was studied for the incidence of tongue cancer and other malignancies during follow-up. A contemporary cohort of 87 patients with tongue cancer, without a history of NPC, was studied for demographic data, cigarette smoking and alcohol consumption habits. These were then compared with all the NPC patients and with the NPC patients who later developed tongue cancers. There was a significantly increased number of tongue cancers following radiotherapy for NPC. The risk of developing tongue cancer after radiotherapy for NPC was 0.13% per patient per year. There was no increase in the number of other malignancies. The association between NPC and tongue cancer was that of a non-random temporal sequence with tongue cancers following NPC but not in the reverse order. The demographic data and smoking and alcohol consumption history of the 7 NPC patients who subsequently developed tongue cancer were significantly different from the de novo tongue cancer patient population. The absence of common aetiological factors between NPC and tongue cancer and the non-random sequence of tongue cancers occurring after NPC suggests that these seven tongue cancers could be radiation induced. The estimated radiation dose received by the part of the tongue developing cancer was substantial and significantly higher than the dose to the cancer-free tongue. An increase of tongue cancers after radiotherapy for NPC is reported and arguments are made in support of the hypothesis that these were radiation-induced malignancies. We suggest a decrease in the volume of tongue included within the planning target volume of NPC in the absence of oropharyngeal and/or parapharyngeal infiltration. Awareness of the association should make early diagnosis of this likely radiation-induced cancer possible.

Purpose: To evaluate the efficacy of high-dose (> or = 60 Gy) reirradiation using mainly external beams in salvaging local failures of nasopharyngeal carcinoma (NPC) after modern primary radical radiotherapy that delivered radical dose-to-target volumes defined by CT scan., Methods and Materials: Nine hundred and three patients with nondisseminated NPC whose primary radical radiotherapy was administered between 1984 and 1989 inclusive were studied. One hundred and seventy-six had local failures comprising 9 persistences and 167 recurrences. In 10 patients the local failures were preceded or accompanied by (within 2 months) distant metastases, and these were given supportive treatment or palliative radiotherapy in low dose (< 60 Gy) if symptomatic. Most of the rest (123 of 166) were treated with either reirradiation to high dose (> or = 60 Gy) using mainly external photon beams (n = 103) or nasopharyngectomy with/without radical neck dissection with/without postoperative radiotherapy (n = 20). The remainder (n = 43) received only palliative treatments because of poor general condition and/or patients' refusal of radical treatments. The primary radiotherapy was planned on the basis of target volumes defined by CT scan and given to a standard nasopharyngeal dose of 62.5 Gy/29 fractions/6 weeks. In the presence of parapharyngeal involvement, an additional boost of 20 Gy/10 fractions/2 weeks was given via a posterior oblique photon beam. If local residual tumors were diagnosed at 4-6 weeks after the completion of external radiotherapy, an additional boost of 24 Gy/3 fractions/15 days was given by intracavitary intubation. For the local failures given high-dose reirradiation, the target volume was defined by CT scan and treated by a two-field or a three-field photon arrangement with or without additional dose supplement by intracavitary intubation. Nasopharyngectomy was performed via the transcervico-mandibulo-palatal approach or the maxillary swing approach. Radical neck dissection was only performed for the clinically evident nodal failures., Results: With a median follow-up of 20 months (range 2.5-81 months) since the diagnosis of local failure, the actuarial 5-year overall survival, further relapse-free survival and free-from-local-tumor rates were 9.4, 11.5, and 18.7%, respectively, for the 123 patients treated by either high-dose reirradiation (n = 103) or nasopharyngectomy (n = 20). Palliatively treated patients (n = 43) had a survival comparable to patients whose local failures were preceded or accompanied by distant metastasis (n = 10). Reirradiation to high dose (> or = 60 Gy) mainly by external photon beams achieved a 5-year overall survival of 7.6% and 5-year local control of 15.2% with significant complications. Radiation-induced temporal lobe encephalopathy was radiologically evident in 21 patients (20.4%), and 13 of these 21 patients were symptomatic. It could have been the cause of death in three patients who also suffered from uncontrolled local tumor. Significant morbidity was also associated with the other frequent radiation complications, including xerostomia, trismus, and deafness. Uni- and multivariate analyses indicated that brief initial disease-free interval between completion of primary radiotherapy and diagnosis of local failures and advanced recurrent T-stage and recurrent N-stage were significant prognosticators predicting poor survival and/or further local failure after reirradiation. These patients were unlikely to benefit from the treatment. Nasopharyngectomy (+/- neck dissection +/- postoperative radiotherapy) was associated with earlier recurrent T-stages (mostly rT1 and rT2) and better survival and local control than reirradiation. However, restricting the comparison to rT1 and rT2 still demonstrated the superior results in favor of nasopharyngectomy, which could not be explained by the selection of less advanced lesions or patients with better performance status for surgery. (ABSTRACT TRUNCATED)

Radical neck dissection (RND) for recurrent nasopharyngeal carcinoma (NPC) after radiotherapy was retrospectively evaluated in 38 patients treated between April 1986 and December 1991. Thirty patients (79%) had advanced-stage disease. Four patients required nasopharyngectomy as well as RND. The mortality was 0%, and the morbidity was 13%. The actuarial survival rates at 5 years from the time of initial radiotherapy and RND were 50% and 25%, respectively. Of the 21 patients with relapses after surgical salvage, 5 had recurrences in the nasopharynx, 3 had recurrences in the neck, and 13 had distant metastases. We conclude that RND for recurrent NPC is safe and efficacious; however, it is associated with a significant (34%) incidence of distant metastases. These results can be improved by evaluating patients for distant metastases and excluding those with distant metastases. Improvement in the treatment of distant metastases is also needed.